Determination of early urinary renal injury markers in obese children

Pediatric Nephrology

Volumn 30, Issue 1, 2015, Pages 139-144

  Goknar, Nilufer ^a   Oktem, Faruk ^a   Ozgen, Ilker Tolga ^a   Torun, Emel ^a   Kuçukkoc, Mehmet ^a   Demir, Aysegul Dogan ^a   Cesur, Yasar ^a  

^a BEZMIALEM VAKIF UNIVERSITY   (Turkey)

Author keywords

Children; Kidney injury molecule 1; N acetyl beta d glucosaminidase; Neutrophil gelatinase associated lipocalcin; Obesity

Indexed keywords

ACETYLGLUCOSAMINIDASE; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; HAVCR1 PROTEIN, HUMAN; LCN2 PROTEIN, HUMAN; LIPOCALIN; MEMBRANE PROTEIN; ONCOPROTEIN; VIRUS RECEPTOR;

ADOLESCENT; CHILD; COMPLICATION; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KIDNEY DISEASES; MALE; OBESITY; PRESCHOOL CHILD; URINE;

ACETYLGLUCOSAMINIDASE; ACUTE-PHASE PROTEINS; ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KIDNEY DISEASES; LIPOCALINS; MALE; MEMBRANE GLYCOPROTEINS; OBESITY; PROTO-ONCOGENE PROTEINS; RECEPTORS, VIRUS;

EID: 84928409496     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-014-2829-0     Document Type: Article

References (44)

1. Henegar JR, Bigler SA, Henegar LK, Tyagi SC, Hall JE (2001) Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 12:1211–1217
2. Ross WR, McGill JB (2006) Epidemiology of obesity and chronic kidney disease. Adv Chronic Kidney Dis 13:324–335
3. Tagle R, Gonzalez F, Acevedo M (2012) Microalbuminuria and urinary albumin excretion in clinical practice. Rev Med Chil 140:797–805
4. Redon J, Martinez F (2012) Microalbuminuria as surrogate endpoint in therapeutic trials. Curr Hypertens Rep 14:345–349
5. Thomas MC, Burns WC, Cooper ME (2005) Tubular changes in early diabetic nephropathy. Adv Chronic Kidney Dis 12:177–186
6. Brito PL, Fioretto P, Drummond K, Kim Y, Steffes MW, Basgen JM, Sisson-Ross S, Mauer M (1998) Proximal tubular basement membrane width in insulin-dependent diabetes mellitus. Kidney Int 53:754–761
7. Soni SS, Cruz D, Bobek I, Chionh CY, Nalesso F, Lentini P, de Cal M, Corradi V, Virzi G, Ronco C (2010) NGAL: a biomarker of acute kidney injury and other systemic conditions. Int Urol Nephrol 42:141–150
8. Han KW, Bailly V, Abichandani R, Thadhani R, Bonventre JV (2002) Kidney injury molecule-1(KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 62:237–244
9. Adiyanti SS, Loho T (2012) Acute kidney injury (AKI) biomarker. Acta Med Indones 44:246–255
10. Kavukçu S, Soylu A, Türkmen M (2002) The clinical value of urinary N-acetyl-β-d-glucosaminidase levels in childhood age group. Acta Med Okayama 56:7–11
11. Mohammadi-Karakani A, Asgharzadeh-Haghighi S, Ghazi-Khansari M, Hosseini R (2007) Determination of urinary enzymes as a marker of early renal damage in diabetic patients. J Clin Lab Anal 21:413–417
12. Nielsen SE, Schjoedt KJ, Astrup AS, Tarnow L, Lajer M, Hansen PR, Parving HH, Rossing P (2010) Neutrophil gelatinase-associated lipocalcin (NGAL) and kidney injury molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril. Diabet Med 27:1144–1150
13. Bonvente JV (2009) Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transplant 24:3165–3168
14. Cowland JB, Sorensen OE, Sehested M, Borregaard N (2003) Neutrophil gelatinase-associated lipocalcin is up-regulated in human epithelial cells by IL-1β, but not TNF-α. J Immunol 171:6630–6639
15. Barlow SE, Committee E (2007) Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 120:164–192
16. Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin N Am 34:571–590
17. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of WHO consultation. Diabet Med 15:539–553
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419
19. Valerio G, Licenziati MR, Iannuzzi A, Franseze A, Siani P, Riccardi G, Rubba P (2006) Insulin resistance and impaired glucose tolerance in obese children and adolescents from southern Italy. Nutr Metab Cardiovasc Dis 16:279–284
20. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576
21. Siedell JC (2000) Obesity, insulin resistance and diabetes—a worldwide epidemic. Br J Nutr 83:5–8
22. Yuca SA, Yilmaz C, Cesur Y, Dogan M, Kaya A, Basaranoglu M (2010) Prevalence of overweight and obesity in children and adolescents in eastern Turkey. J Clin Res Pediatr Endocrinol 2:159–163
23. Krassas GE, Tsametis C, Baleki V, Constantinidis T, Unluhizarci K, Kurtoglu S, Kelestimur F (2004) Balkan group for the study of obesity. Prevalence of overweight and obesity among children and adolescents in Thessaloniki-Greece and Kayseri-Turkey. Pediatr Endocrinol Rev 3:460–464
24. Ercan S, Dallar YB, Onen S, Engiz O (2012) Prevalence of obesity and associated risk factors among adolescents in Ankara, Turkey. J Clin Res Pediatr Endocrinol 4:204–207
25. Soylemezoglu O, Duzova A, Yalcinkaya F, Arınsoy T, Suleymanlar G (2012) Chronic renal disease in children aged 5-18 years: a population-based survey in Turkey, the CREDIT-C study. Nephrol Dial Transplant 27:146–151
26. Ginter E, Simko V (2012) Type 2 diabetes mellitus, pandemic in 21st century. Adv Exp Med Biol 771:42–50
27. Adeghate E, Schattner P, Dunn E (2006) An update on the etiology and epidemiology of diabetes mellitus. Ann N Y Acad Sci 1084:1–29
28. Wofford MR, Hall JE (2004) Pathophysiology and treatment of obesity hypertension. Curr Pharm Des 10:3621–3637
29. Kordonouri O, Kahl A, Jörres A, Hopfenmüller W, Müller C, Danne T (1999) The prevalence of incipient tubular dysfunction, but not of glomerular dysfunction, is increased in patients with diabetes onset in childhood. J Diabetes Complications 13:320–324
30. Bolignano D, Lacquaniti A, Coppolino G, Donato V, Fazio MR, Nicocia G, Buemi M (2009) Neutrophil gelatinase-associated lipocalcin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press Res 32:91–98
31. Fujita H, Narita T, Morii T, Shimotomai T, Yoshioka N, Kakei M, Ito S (2002) Increased urinary excretion of N-acetylglucosaminidase in subjects with impaired glucose tolerance. Ren Fail 24:69–75
32. Golov KG, Va V, Dlu O, Neverov NI, Shestakova MV, Proskurneva FP (1995) Urinary enzymes in the assessment of the early stage of kidney involvement in psoriasis and diabetes mellitus. Ter Arkh 67:80–81
33. Hsiao PH, Tsai WS, Tsai WY, Js L, Tsau YK, Chen CH (1996) Urinary N-acetyl-beta-d-glucosaminidase activity in children with insulin-dependent diabetes mellitus. Am J Nephrol 16:300–303
34. Savino A, Pelliccia P, Giannini C, Giorgis T, Cataldo I, Chiarelli F, Mohn A (2011) Implications for kidney disease in obese children and adolescents. Pediatr Nephrol 26:749–758
35. Nauta FL, Boertien WE, Bakker SJ, van Goor H, van Oeveren W, de Jong PE, Bilo H, Gansevoort RT (2011) Glomerular and tubular damage markers are elevated in patients with diabetes. Diabetes Care 34:975–981
36. Bastürk T, Altuntaş Y, Kurklu A, Aydin L, Eren N, Unsal A (2006) Urinary N-acetyl-β glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination. Ren Fail 28:125–128
37. 2 microglobulin in patients with impaired glucose tolerance. J Clin Lab Anal 12:351–355
38. Kern EF, Erhard P, Sun W, Genuth S, Weiss MF (2010) Early urinary markers of diabetic kidney disease: a nested case-control study from the Diabetes Control and Complications Trial(DCCT). Am J Kidney Dis 55:824–834
39. Chagnac A, Herman M, Zingerman B, Erman A, Rozen-Zvi B, Hirsh J, Gafter U (2008) Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption. Nephrol Dial Transplant 23:3946–3952
40. Duzova A, Yalcinkaya F, Baskin E, Bakkaloğlu A, Soylemezoglu O (2013) Prevalence of hypertension and decreased glomerular filtration rate in obese children: results of a population-based field study. Nephrol Dial Transplant 28:166–171
41. Ouchi M, Suzuki T, Hashimoto M, Motomoya, Ohara M, Suzuki K, Igari Y, Watanabe K, Nakano H, Oba K (2012) Urinary N-acetyl-β-d-glucosaminidase levels are positively correlated with 2-Hr plasma glucose levels during oral glucose tolerance testing in prediabetics. J Clin Lab Anal 26:473–480
42. Schnoell F, Weitgasser R, Straberger A, Pretsch I (1990) Urinary activity of N-acetyl-β-d-glucosaminidase (NAG) in noninsulin-dependent diabetics. Diabetologia 33:A153
43. Miltenyi M, Körner A, Tulassay T, Szabo A (1985) Tubular dysfunction in type 1 diabetes mellitus. Arch Dis Child 60:929–931
44. Quinones-Galvan A, Ferrannini E (1997) Renal effects of insulin in man. J Nephrol 10:188–191